Product Information
HYDROXYCHLOROQUINE 200 MG TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1485 per EA under NDC 00093240101. Its NADAC has been published 297 times since Dec 16, 2020.
FDA first approved this application on Sep 30, 1994. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093240101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROXYCHLOROQUINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA040081FDA Approved
9/30/1994
TE Code
AB
On Market Since
10/8/2020
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYCHLOROQUINE 200 MG TAB has been published 297 times since Dec 16, 2020, and over the history we have for it it has declined 47.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1485 per EA |
|---|---|
| All-time high | $0.2863 (May 12, 2021) |
| All-time low | $0.1399 (Nov 20, 2024) |
| 52-week high | $0.1643 |
| 52-week low | $0.1485 |
| Median price | $0.1956 |
| Average price | $0.2032 |
| Largest weekly change | -20.5% (Nov 20, 2024) |
| Weeks tracked | 297 |
| Tracking since | Dec 16, 2020 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROXYCHLOROQUINE 200 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYCHLOROQUINE 200 MG TAB, manufactured by Teva Pharmaceuticals USA Inc., is $0.1485 per EA (NDC 00093240101), effective Aug 19, 2026.
How has the price of HYDROXYCHLOROQUINE 200 MG TAB changed over time?
Over the history we have for it, the NADAC for HYDROXYCHLOROQUINE 200 MG TAB has declined 47.1%. It has been tracked across 297 weekly CMS publications since Dec 16, 2020.
What are the highest and lowest recorded NADAC prices for HYDROXYCHLOROQUINE 200 MG TAB?
Since Dec 16, 2020, the NADAC for HYDROXYCHLOROQUINE 200 MG TAB has ranged from a low of $0.1399 (Nov 20, 2024) to a high of $0.2863 (May 12, 2021), with a median of $0.1956 per EA.
Are there cheaper alternatives to HYDROXYCHLOROQUINE 200 MG TAB?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDROXYCHLOROQUINE 200 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDROXYCHLOROQUINE 200 MG TAB?
HYDROXYCHLOROQUINE 200 MG TAB (NDC 00093240101) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.